Cutivate

Cutivate Indications/Uses

fluticasone

Manufacturer:

GlaxoSmithKline

Distributor:

Zuellig Pharma
Full Prescribing Info
Indications/Uses
Treatment of Inflammatory Dermatoses: CUTIVATE Cream is indicated for adults and children aged 1 year and over for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses such as: Eczema including atopic, infantile, and discoid eczemas; Prurigo nodularis; Psoriasis (excluding widespread plaque psoriasis); Neurodermatoses including lichen simplex; Lichen planus; Seborrhoeic dermatitis; Contact sensitivity reactions; Discoid lupus erythematosus; An adjunct to systemic steroid therapy in generalised erythroderma; Insect bite reactions; Prickly heat.
CUTIVATE Cream is indicated for children aged 3 months to less than 1 year for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses such as: Eczema including atopic, infantile, and discoid eczemas; Prurigo nodularis; Psoriasis (excluding widespread plaque psoriasis); Neurodermatoses including lichen simplex; Lichen planus; Seborrhoeic dermatitis; Contact sensitivity reactions; Discoid lupus erythematosus; An adjunct to systemic steroid therapy in generalised erythroderma.
The safety and efficacy of drug use for longer than 4 weeks in this population have not been established. The safety and efficacy of CUTIVATE Cream in paediatric patients below 3 months of age have not been established.
Reduction of Risk of Relapse: CUTIVATE Cream is indicated for the reduction of the risk of relapse of chronic recurrent atopic eczema once an acute episode has been treated effectively.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in